Bryostatin 1 and phorbol ester down-modulate protein kinase C-α and - ε via the ubiquitin/proteasome pathway in human fibroblasts

Molecular Pharmacology

Volumn 51, Issue 3, 1997, Pages 439-447

  Lee, Hyeon Woo ^a   Smith, Lucinda ^a   Pettit, George R ^b   Smith, Jeffrey Bingham ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c Dept of Pharmacology and Toxicology Volker Hall G133E ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; CALPAIN; ENZYME INHIBITOR; OKADAIC ACID; ORTHOVANADIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEASOME; PROTEIN KINASE C; TETRAPEPTIDE; TRIPEPTIDE; UBIQUITIN;

ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN FIBROBLAST;

EID: 0030894069     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mahoney, C. W., and K.-P. Huang. Molecular and catalytic properties of protein kinase C, in Protein Kinase C (J. F. Kuo, ed.). Oxford University Press, New York, 16-63 (1994).
2. Newton, A. C. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270:28495-28498 (1995).
3. Smith, J. B., L. Smith, and G. R. Pettit. Bryostatins: potent new mitogens that mimic phorbol ester tumor promoters. Biochem. Biophys. Res. Commun. 132:939-945 (1985).
4. Szallasi, Z., C. B. Smith, G. R. Pettit, and P. M. Blumberg. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem. 269:2118-2124 (1994).
5. Huwiler, A., D. Fabbro, and J. Pfeilschifter. Comparison of different tumour promoters and bryostatin 1 on protein kinase C activation and down-regulation in rat renal mesangial cells. Biochem. Pharmacol. 48: 689-700 (1994).
6. Burns, D. J., and R. M. Bell. Protein kinase C contains two phorbol ester binding domains. J. Biol. Chem. 266:18330-18338 (1991).
7. Slater, S. J., C. Ho, M. B. Kelly, J. D. Larkin, F. J. Taddeo, M. D. Yeager, and C. D. Stubbs. Protein kinase Cα contains two activator binding sites that bind phorbol esters and diacylglycerols with opposite affinities. J. Biol. Chem. 271:4627-4631 (1996).
8. Szallasi, Z., K. Bogi, S. Gohari, T. Biro, P. Acs, and P. M. Blumberg. Non-equivalent roles for the first and second zinc fingers of protein kinase Cδ: effect of their mutation on phorbol ester-induced translocation in NIH 3T3 cells. J. Biol. Chem. 271:18299-18301 (1996).
9. Hennings, H., P. M. Blumberg, G. R. Pettit, C. L. Herald, R. Shores, and S. H. Yupsa. Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8:1343-1346 (1987).
10. Kraft, A. S., J. B. Smith, and R. L. Berkow. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Proc. Natl. Acad. Sci. USA 83:1334-1338 (1986).
11. Tallant, A., J. B. Smith, and R. W. Wallace. Bryostatins mimic the effects of phorbol esters on the activation of protein kinase C in intact human platelets. Biochim. Biophys. Acta 929:40-46 (1987).
12. Sako, T., S. H. Yupsa, C. L. Herald, G. R. Pettit, and P. M. Blumberg. Partial parallelism and partial blockage by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Cancer Res. 47:5445-5450 (1987).
13. Isakov, N., D. Galron, T. Mustelin, G. R. Pettit, and A. Altman. Inhibition of phorbol ester-induced T-cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. J. Immunol. 150:1195-1204 (1993).
14. Lee, H.-W., L. Smith, G. R. Pettit, and J. B. Smith. Dephosphorylation of activated protein kinase C contributes to downregulation by bryostatin. Am. J. Physiol. 271:C304-C311 (1996).
15. Young, S., P. J. Parker, A. Ullrich, and S. Stabel. Down-regulation of protein kinase C is due to an increased rate of degradation. Biochem. J. 244:775-779 (1987).
16. Lee, H.-W., L. Smith, G. R. Pettit, A. Vinitsky, and J. B. Smith. Ubiquitination of protein kinase C-α and degradation by the proteasome. J. Biol. Chem. 271:20973-20976 (1996).
17. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 79: 13-21 (1994).
18. Rechsteiner, M., and S. W. Rogers. PEST sequences and regulation by proteolysis. Trends. Biochem. Sci. 21:267-271 (1996).
19. Fenteany, G., R. F. Standaert, W. S. Lane., S. Choi, E. J. Corey, and S. L. Schreiber. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (Washington D. C.) 268:726-731 (1995).
20. 3 domain mutants with differential sensitivities to m-calpain are not resistant to phorbol-ester-induced down-regulation. Eur. J. Biochem. 223:259-263 (1994).
21. Goode, N. T., M. A. N. Hajibagheri, and P. J. Parker. Protein kinase C (PKC)-induced PKC down-regulation: association with up-regulation of vesicle traffic. J. Biol. Chem. 270:2669-2773 (1995).
22. 1 cells. J. Biol. Chem. 270:25115-25120 (1995).
23. Kishimoto, A., K. Mikawa, K. Hashimoto, I. Yasuda, S.-I. Tanaka, M. Tominaga, T. Kuroda, and Y. Nishizuka. Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J. Biol. Chem. 264:4088-4092 (1989).
24. 2+ mobilization. J. Biol. Chem. 264:831-337 (1989).
25. Pettit, G. R., C. L. Herald, D. L. Doubek, and D. L. Herald, E. Arnold, and J. Clardy. Isolation and structure of bryostatin 1. J. Am. Chem. Soc. 104:6846-6848 (1982).
26. Lee, H.-W. Bryostatin downregulates protein kinase C by production of incompetent enzyme and degradation by the ubiquitin-proteasome pathway. Doctoral dissertation, University of Alabama at Birmingham, Birmingham, AL (1996).
27. Shoji-Kasai, Y., M. Senshu, S. Iwashita, and K. Imahori. Thiol protease-specific inhibitor E-64 arrests human epidermoid carcinoma A431 cells at mitotic metaphase. Proc. Natl. Acad. Sci. USA 85:146-150 (1988).
28. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771 (1994).
29. Sepp-Lorenzino, L., Z. Ma, D. E. Lebwohl, A. Vinitsky, and N. Rosen. Herbimycin A induces the 20 S proteasome- and ubiquitin-dependent degradation of receptor tyrosine kinases. J. Biol. Chem. 270:16580-16587 (1995).
30. Tartakoff, A. M. Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32:1026-1028 (1983).
31. Pelham, H. R. B. Multiple targets of brefeldin A. Cell 67:449-451 (1991).
32. Cohen, P., and P. T. W. Cohen. Protein phosphatases come of age. J. Biol. Chem. 264:21435-21438 (1989).
33. Guarino, L. A., G. Smith, and W. Dong. Ubiquitin is attached to membranes of baculovirus particles by a novel type of phospholipid anchor. Cell 80:301-309 (1995).
34. Haas, A. L., and P. M. Bright. The immunochemical detection and quantitation of intracellular ubiquitin-protein conjugates. J. Biol. Chem. 260: 12464-12473 (1985).
35. 2 in Mos. EMBO J. 12:4021-4027 (1993).
36. Rechsteiner, M. Regulation of enzyme levels by proteolysis: the role of PEST regions. Adv. Enzyme Regul. 27:135-151 (1988).
37. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Washington D. C.) 267:1485-1488 (1995).
38. Lahav-Baratz, S., V. Sudakin, J. V. Ruderman, and A. Hershko. Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase. Proc. Natl. Acad. Sci. USA 92:9303-9307 (1995).
39. Papavassiliou, A. G., M. Treier, C. Chavrier, and D. Hohmann. Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun. Science (Washington D. C.) 258:1941-1944 (1992).
40. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. Signal-induced site-specific phosphorylation targets IεBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597 (1995).